In the comparable SCOT-HEART trial, hs-cTnI measured with the same SMC assay displayed similar reclassification abilities when added to the CAD Consortium score for pre-test probability of obstructive CAD, mainly by downgrading the risk attributed to intermediate and high-risk patients35. The gene discussed is TNNI3; the disease is coronary artery disorder.